Lexington buys into bioventure funds

Abingworth Bioventures III and IV invested in bone and joint medication company Galápagos and women's health company Gynesonics, respectively.

To view this content you must sign in:

Not yet registered? Join today to access Secondaries Investor's industry insights and updates.